Competitive Problems in the Drug Industry : Summary and Analysis.
Prepared by CRS, summarizes first 17 volumes of testimony from hearings before the Subcom on Monopoly, held during the 90th and 91st Congresses, on the status of competition in the prescription drug industry.
| Corporate Authors: | , |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
1972.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Prepared by CRS, summarizes first 17 volumes of testimony from hearings before the Subcom on Monopoly, held during the 90th and 91st Congresses, on the status of competition in the prescription drug industry. Aspects covered include drug prices and profits, product development and patents, promotion and advertising, brand and trade names, quality control, and drug safety. Also summarizes witness' proposals and recommendations. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |